| Code | Description | Claims | Beneficiaries | Total Paid |
| 99223 |
Prolong inpt eval add15 m |
1,006 |
956 |
$376K |
| 99199 |
Unlisted special service, procedure or report |
7,017 |
6,399 |
$283K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,031 |
6,506 |
$194K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,740 |
7,604 |
$147K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,063 |
1,265 |
$133K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,025 |
3,016 |
$129K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,298 |
29,003 |
$121K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,197 |
1,077 |
$98K |
| 59425 |
|
1,689 |
1,059 |
$85K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,683 |
1,677 |
$85K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
668 |
423 |
$82K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,774 |
1,760 |
$80K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,346 |
1,293 |
$80K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,031 |
2,011 |
$79K |
| 82785 |
|
419 |
419 |
$64K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
1,038 |
632 |
$62K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
533 |
475 |
$60K |
| 86003 |
|
635 |
632 |
$56K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,516 |
1,514 |
$56K |
| 99215 |
Prolong outpt/office vis |
341 |
323 |
$52K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
706 |
675 |
$52K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
447 |
388 |
$48K |
| E1390 |
Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate |
408 |
396 |
$48K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
418 |
405 |
$44K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,541 |
1,535 |
$43K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
928 |
898 |
$43K |
| 88142 |
|
888 |
888 |
$43K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
72 |
72 |
$38K |
| 99243 |
|
663 |
613 |
$35K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
709 |
374 |
$30K |
| 97010 |
|
799 |
234 |
$30K |
| 0450 |
Emergency room services |
619 |
587 |
$30K |
| J3490 |
Unclassified drugs |
234 |
188 |
$29K |
| 64493 |
|
141 |
70 |
$23K |
| E0601 |
Continuous positive airway pressure (cpap) device |
412 |
395 |
$20K |
| 92134 |
|
109 |
94 |
$20K |
| 64483 |
|
56 |
56 |
$18K |
| 92552 |
|
6,616 |
6,572 |
$16K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
166 |
146 |
$15K |
| T4541 |
Incontinence product, disposable underpad, large, each |
492 |
488 |
$15K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
108 |
100 |
$15K |
| 80053 |
Comprehensive metabolic panel |
10,804 |
9,504 |
$14K |
| E0443 |
Portable oxygen contents, gaseous, 1 month's supply = 1 unit |
124 |
123 |
$14K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
787 |
243 |
$14K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
290 |
288 |
$14K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,972 |
4,944 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,498 |
12,247 |
$13K |
| 97803 |
|
1,080 |
978 |
$12K |
| 95117 |
|
1,708 |
522 |
$12K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
105 |
105 |
$12K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
25 |
24 |
$12K |
| 71045 |
Radiologic examination, chest; single view |
712 |
649 |
$11K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
153 |
148 |
$11K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
110 |
109 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
572 |
552 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,077 |
871 |
$10K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
213 |
208 |
$9K |
| 95811 |
|
25 |
25 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
538 |
534 |
$9K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
126 |
82 |
$8K |
| 97802 |
|
2,095 |
1,985 |
$7K |
| 76881 |
|
64 |
61 |
$7K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,294 |
386 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
408 |
350 |
$7K |
| 92060 |
|
4,993 |
4,960 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
48 |
45 |
$6K |
| E0431 |
Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing |
316 |
310 |
$6K |
| K0001 |
Standard wheelchair |
193 |
191 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,612 |
8,277 |
$5K |
| 99383 |
|
81 |
81 |
$5K |
| 99233 |
Prolong inpt eval add15 m |
270 |
114 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
5,707 |
5,490 |
$5K |
| 90686 |
|
680 |
675 |
$5K |
| 85018 |
|
4,338 |
4,299 |
$5K |
| 80061 |
Lipid panel |
6,120 |
6,088 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,183 |
2,382 |
$4K |
| 59514 |
|
13 |
12 |
$4K |
| 99384 |
|
61 |
61 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,248 |
2,166 |
$4K |
| 86580 |
|
1,693 |
1,688 |
$4K |
| T4535 |
Disposable liner/shield/guard/pad/undergarment, for incontinence, each |
178 |
178 |
$4K |
| 59025 |
Fetal non-stress test |
65 |
42 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
184 |
46 |
$4K |
| 90715 |
|
342 |
340 |
$4K |
| 92250 |
|
40 |
40 |
$4K |
| 95144 |
|
40 |
40 |
$4K |
| 99460 |
|
46 |
46 |
$4K |
| 81025 |
|
1,299 |
1,241 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
398 |
359 |
$3K |
| 84702 |
|
750 |
681 |
$3K |
| T4527 |
Adult sized disposable incontinence product, protective underwear/pull-on, large size, each |
57 |
57 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,373 |
5,324 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,490 |
2,481 |
$3K |
| 81001 |
|
2,955 |
2,859 |
$3K |
| 92557 |
|
26 |
26 |
$3K |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
985 |
979 |
$3K |
| 97162 |
|
37 |
36 |
$3K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
15 |
15 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
100 |
97 |
$3K |
| 86592 |
|
2,415 |
2,397 |
$3K |
| 99382 |
|
42 |
42 |
$2K |
| E0570 |
Nebulizer, with compressor |
34 |
34 |
$2K |
| 76801 |
|
24 |
24 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
84 |
82 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
14 |
14 |
$2K |
| 87088 |
|
622 |
613 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
17 |
13 |
$2K |
| 81003 |
|
4,330 |
4,218 |
$2K |
| E0562 |
Humidifier, heated, used with positive airway pressure device |
346 |
344 |
$2K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
414 |
217 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
24 |
21 |
$2K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
56 |
51 |
$2K |
| T4526 |
Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each |
48 |
48 |
$2K |
| 81000 |
|
3,048 |
2,910 |
$2K |
| 83690 |
|
1,138 |
1,047 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
53 |
52 |
$2K |
| 84484 |
|
752 |
639 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
39 |
36 |
$2K |
| 90651 |
|
459 |
454 |
$2K |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
105 |
105 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,774 |
1,768 |
$1K |
| 97001 |
|
26 |
13 |
$1K |
| 3008F |
|
5,568 |
5,260 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
606 |
487 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
154 |
150 |
$1K |
| 88112 |
|
15 |
14 |
$1K |
| 97161 |
|
24 |
24 |
$1K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
15 |
12 |
$1K |
| T4523 |
Adult sized disposable incontinence product, brief/diaper, large, each |
27 |
27 |
$1K |
| 90648 |
|
293 |
293 |
$1K |
| 86038 |
|
312 |
310 |
$1K |
| A4927 |
Gloves, non-sterile, per 100 |
113 |
113 |
$1K |
| 82728 |
|
398 |
390 |
$1K |
| 82746 |
|
294 |
293 |
$1K |
| 99205 |
Prolong outpt/office vis |
39 |
39 |
$1K |
| 85610 |
|
1,699 |
1,481 |
$1K |
| 82947 |
|
676 |
662 |
$1K |
| 84439 |
|
1,516 |
1,508 |
$997.27 |
| 88141 |
|
202 |
202 |
$983.42 |
| 85027 |
|
1,319 |
1,107 |
$978.39 |
| 85730 |
|
1,132 |
1,010 |
$894.95 |
| 90670 |
|
581 |
571 |
$884.16 |
| 94760 |
|
587 |
527 |
$850.00 |
| 99381 |
|
13 |
13 |
$833.15 |
| 90700 |
|
534 |
533 |
$828.00 |
| 92235 |
|
28 |
28 |
$801.74 |
| 82784 |
|
25 |
25 |
$741.94 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
817 |
802 |
$732.17 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
29 |
25 |
$689.54 |
| 90707 |
|
280 |
280 |
$679.76 |
| A4335 |
Incontinence supply; miscellaneous |
64 |
56 |
$677.19 |
| 86900 |
|
868 |
771 |
$619.63 |
| 90658 |
|
365 |
365 |
$615.48 |
| 84703 |
|
435 |
417 |
$605.70 |
| 86005 |
|
28 |
28 |
$587.55 |
| 83540 |
|
523 |
517 |
$577.95 |
| 90649 |
|
205 |
205 |
$558.65 |
| 80076 |
|
1,098 |
1,007 |
$558.43 |
| 83880 |
|
61 |
57 |
$557.86 |
| 90713 |
|
326 |
325 |
$557.33 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
189 |
177 |
$540.42 |
| 83735 |
|
371 |
299 |
$531.50 |
| 86901 |
|
826 |
733 |
$527.79 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
159 |
146 |
$525.79 |
| 87186 |
|
523 |
516 |
$520.05 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
36 |
12 |
$512.44 |
| 90633 |
|
328 |
323 |
$503.22 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
26 |
26 |
$494.76 |
| 0250 |
|
62 |
59 |
$481.05 |
| 97014 |
|
1,026 |
309 |
$470.00 |
| 93000 |
|
297 |
294 |
$455.12 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
144 |
97 |
$447.50 |
| 92083 |
|
14 |
14 |
$414.15 |
| A0425 |
Ground mileage, per statute mile |
1,913 |
1,312 |
$404.39 |
| 85652 |
|
698 |
693 |
$379.30 |
| 92133 |
|
14 |
14 |
$376.56 |
| 87070 |
|
162 |
160 |
$375.95 |
| 90716 |
|
308 |
308 |
$371.95 |
| 90696 |
|
86 |
84 |
$360.00 |
| 90620 |
|
63 |
63 |
$352.82 |
| 99000 |
|
485 |
466 |
$352.59 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
185 |
173 |
$337.58 |
| A7035 |
Headgear used with positive airway pressure device |
15 |
15 |
$318.73 |
| 82570 |
|
771 |
765 |
$308.48 |
| 86803 |
|
142 |
141 |
$293.41 |
| 84153 |
|
619 |
610 |
$289.68 |
| 0270 |
|
348 |
316 |
$285.56 |
| 73610 |
|
14 |
13 |
$273.55 |
| 90734 |
|
336 |
332 |
$270.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15 |
14 |
$262.55 |
| 88150 |
|
134 |
123 |
$250.00 |
| 87340 |
|
369 |
368 |
$239.25 |
| 0637 |
|
47 |
47 |
$238.96 |
| 81002 |
|
967 |
883 |
$234.64 |
| A7038 |
Filter, disposable, used with positive airway pressure device |
27 |
27 |
$227.53 |
| 81329 |
|
28 |
27 |
$217.00 |
| 82607 |
|
460 |
459 |
$216.97 |
| 84550 |
|
938 |
932 |
$214.73 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
209 |
151 |
$204.36 |
| 82274 |
|
381 |
335 |
$199.68 |
| 86140 |
|
572 |
546 |
$196.50 |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
13 |
13 |
$188.37 |
| 82043 |
|
1,050 |
1,046 |
$187.39 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
27 |
25 |
$183.80 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
71 |
71 |
$180.60 |
| 87077 |
|
224 |
221 |
$177.05 |
| A4253 |
Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips |
66 |
62 |
$175.63 |
| 83970 |
|
39 |
38 |
$168.85 |
| 84436 |
|
788 |
787 |
$157.99 |
| 82565 |
|
216 |
215 |
$153.91 |
| 87081 |
|
323 |
321 |
$151.29 |
| 83550 |
|
446 |
440 |
$145.56 |
| 76830 |
Ultrasound, transvaginal |
13 |
13 |
$140.73 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
19 |
18 |
$135.42 |
| 99401 |
|
283 |
253 |
$131.17 |
| 86769 |
|
13 |
12 |
$125.55 |
| A4267 |
Contraceptive supply, condom, male, each |
42 |
40 |
$122.91 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
76 |
66 |
$119.48 |
| 90672 |
|
139 |
139 |
$117.00 |
| 80074 |
|
294 |
288 |
$116.81 |
| 83655 |
|
377 |
377 |
$109.54 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,598 |
1,563 |
$108.78 |
| 84460 |
|
149 |
148 |
$105.56 |
| 86480 |
|
229 |
228 |
$104.12 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
44 |
43 |
$100.00 |
| 84481 |
|
107 |
106 |
$96.83 |
| A4590 |
Special casting material (e.g., fiberglass) |
76 |
71 |
$90.00 |
| 3078F |
|
3,061 |
2,920 |
$87.98 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
51 |
44 |
$81.90 |
| 84100 |
|
162 |
148 |
$81.45 |
| 84479 |
|
656 |
655 |
$70.43 |
| 97035 |
|
506 |
153 |
$68.70 |
| 82550 |
|
77 |
73 |
$67.72 |
| 92551 |
|
1,102 |
1,101 |
$63.98 |
| 80051 |
|
16 |
16 |
$60.54 |
| 83013 |
|
12 |
12 |
$59.28 |
| G9920 |
Screening performed and negative |
1,232 |
1,231 |
$58.00 |
| 87210 |
|
30 |
28 |
$52.44 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
48 |
48 |
$50.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
373 |
308 |
$49.92 |
| 84480 |
|
401 |
400 |
$48.61 |
| 86431 |
|
318 |
316 |
$46.53 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
311 |
310 |
$45.00 |
| 86762 |
|
288 |
287 |
$43.44 |
| 86850 |
|
532 |
494 |
$41.94 |
| 82040 |
|
82 |
82 |
$39.56 |
| 3074F |
|
3,128 |
2,981 |
$37.50 |
| 84520 |
|
41 |
41 |
$36.87 |
| 82950 |
|
239 |
237 |
$36.30 |
| 84146 |
|
18 |
18 |
$34.05 |
| 83001 |
|
13 |
13 |
$31.12 |
| 83002 |
|
12 |
12 |
$31.04 |
| 90744 |
|
42 |
42 |
$27.00 |
| 90680 |
|
104 |
104 |
$27.00 |
| 87806 |
|
13 |
12 |
$26.22 |
| 92015 |
Determination of refractive state |
630 |
629 |
$25.00 |
| 84450 |
|
157 |
157 |
$23.88 |
| V2020 |
Frames, purchases |
13 |
13 |
$21.31 |
| 90710 |
|
14 |
13 |
$18.00 |
| 90723 |
|
48 |
48 |
$18.00 |
| 99442 |
|
419 |
374 |
$16.75 |
| 82310 |
|
15 |
14 |
$16.32 |
| 82150 |
|
27 |
26 |
$14.40 |
| 99173 |
|
1,734 |
1,726 |
$13.34 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$12.00 |
| 82248 |
|
25 |
25 |
$11.35 |
| 82962 |
|
800 |
256 |
$9.90 |
| 96156 |
|
61 |
59 |
$8.41 |
| 83050 |
|
597 |
596 |
$8.08 |
| 80069 |
|
54 |
53 |
$7.52 |
| 84075 |
|
28 |
28 |
$7.36 |
| 82247 |
|
27 |
27 |
$7.16 |
| 20553 |
|
41 |
40 |
$7.03 |
| 84155 |
|
15 |
15 |
$2.90 |
| 85651 |
|
13 |
13 |
$1.88 |
| 1160F |
|
683 |
662 |
$0.00 |
| 1159F |
|
877 |
834 |
$0.00 |
| 84295 |
|
62 |
49 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
545 |
545 |
$0.00 |
| 99051 |
|
258 |
245 |
$0.00 |
| 90621 |
|
12 |
12 |
$0.00 |
| 86677 |
|
15 |
14 |
$0.00 |
| 86318 |
|
51 |
51 |
$0.00 |
| A0424 |
Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review) |
316 |
282 |
$0.00 |
| 83026 |
|
56 |
56 |
$0.00 |
| 92081 |
|
670 |
670 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
230 |
227 |
$0.00 |
| 64495 |
|
138 |
67 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
65 |
59 |
$0.00 |
| 96160 |
|
279 |
278 |
$0.00 |
| 81401 |
|
25 |
25 |
$0.00 |
| 85014 |
|
101 |
96 |
$0.00 |
| 85007 |
|
256 |
117 |
$0.00 |
| 87150 |
|
118 |
118 |
$0.00 |
| A0382 |
Bls routine disposable supplies |
63 |
54 |
$0.00 |
| 3077F |
|
46 |
44 |
$0.00 |
| 81479 |
Unlisted molecular pathology procedure |
26 |
26 |
$0.00 |
| A0422 |
Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation |
113 |
81 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
18 |
18 |
$0.00 |
| 3725F |
|
45 |
45 |
$0.00 |
| 0521F |
|
28 |
27 |
$0.00 |
| J9035 |
Injection, bevacizumab, 10 mg |
12 |
12 |
$0.00 |
| 91300 |
|
17 |
17 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
47 |
43 |
$0.00 |
| 86696 |
|
15 |
15 |
$0.00 |
| 2022F |
|
84 |
82 |
$0.00 |
| 90461 |
|
12 |
12 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
18 |
18 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
12 |
12 |
$0.00 |
| 0002A |
|
14 |
14 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15 |
14 |
$0.00 |
| 82465 |
|
16 |
16 |
$0.00 |
| 90685 |
|
13 |
13 |
$0.00 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
18 |
15 |
$0.00 |
| 84403 |
|
12 |
12 |
$0.00 |
| 90647 |
|
53 |
53 |
$0.00 |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
395 |
395 |
$0.00 |
| A0420 |
Ambulance waiting time (als or bls), one half (1/2) hour increments |
98 |
76 |
$0.00 |
| A0999 |
Unlisted ambulance service |
119 |
95 |
$0.00 |
| 92499 |
|
265 |
262 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
98 |
90 |
$0.00 |
| 0001A |
|
33 |
33 |
$0.00 |
| 99406 |
|
380 |
355 |
$0.00 |
| 1000F |
|
12 |
12 |
$0.00 |
| 90698 |
|
87 |
83 |
$0.00 |
| 4000F |
|
385 |
384 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
170 |
170 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
311 |
310 |
$0.00 |
| 1036F |
|
180 |
179 |
$0.00 |
| 64494 |
|
141 |
70 |
$0.00 |
| 94761 |
|
110 |
99 |
$0.00 |
| 99050 |
|
272 |
259 |
$0.00 |
| 3079F |
|
225 |
219 |
$0.00 |
| 87040 |
|
154 |
137 |
$0.00 |
| 76641 |
|
171 |
101 |
$0.00 |
| A0398 |
Als routine disposable supplies |
71 |
63 |
$0.00 |
| 90688 |
|
12 |
12 |
$0.00 |
| 64484 |
|
112 |
56 |
$0.00 |
| 86780 |
|
31 |
26 |
$0.00 |
| 99447 |
|
121 |
95 |
$0.00 |
| 3044F |
|
33 |
28 |
$0.00 |
| S9542 |
Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
21 |
17 |
$0.00 |
| 1126F |
|
45 |
40 |
$0.00 |
| 1170F |
|
33 |
31 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
15 |
15 |
$0.00 |
| 80050 |
General health panel |
45 |
45 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
19 |
17 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
161 |
161 |
$0.00 |
| 81015 |
|
12 |
12 |
$0.00 |
| 0012A |
|
58 |
58 |
$0.00 |
| A7037 |
Tubing used with positive airway pressure device |
13 |
13 |
$0.00 |
| 99441 |
|
13 |
13 |
$0.00 |
| 96127 |
|
73 |
73 |
$0.00 |
| 4050F |
|
14 |
13 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
40 |
38 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
32 |
30 |
$0.00 |
| 3075F |
|
12 |
12 |
$0.00 |
| 1101F |
|
21 |
21 |
$0.00 |
| 0011A |
|
28 |
28 |
$0.00 |
| 87205 |
|
16 |
12 |
$0.00 |
| 99462 |
|
43 |
32 |
$0.00 |
| 83520 |
|
17 |
12 |
$0.00 |
| 1220F |
|
13 |
13 |
$0.00 |
| 80047 |
|
12 |
12 |
$0.00 |
| 2000F |
|
17 |
17 |
$0.00 |
| 86695 |
|
14 |
14 |
$0.00 |
| 3080F |
|
12 |
12 |
$0.00 |
| 92002 |
|
29 |
29 |
$0.00 |
| 36410 |
|
13 |
12 |
$0.00 |